Skip to main content

Tecan to present at upcoming Investor Conferences

Written by Customer Service on . Posted in Public Companies.

Männedorf, Switzerland, November 13, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the following investor conferences in the coming weeks:CS Swiss EQ Mid Cap Conference, Zurich, Switzerland
 Date: 15 November 2019, 10:30 am CET
Presenter: Dr. Achim von Leoprechting, CEO, Tecan
Not webcastedJefferies London Healthcare Conference, London, UK
Date: 20 November 2019, 1:20 pm GMT (2:20 pm CET)
Presenter: Dr. Achim von Leoprechting, CEO, Tecan
Webcast live under the “Investor Relations” tab of Tecan’s website www.tecan.com  
A replay of the webcast will be available after the presentation and will remain available for 90 days.Berenberg European Conference 2019, Pennyhill Park, UK
 Date: 3 and 4 December 2019
Presentation: 3 December 2019, 4:00 pm GMT (5:00 pm CET)
Presenter: Dr. Achim von Leoprechting, CEO, Tecan
Not webcastedAbout Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2018, Tecan generated sales of CHF 594 million (USD 606 million; EUR 516 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).For further information:Tecan Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.comAttachmentPress Release

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.